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Abstract
Background: In Switzerland, general practitioners (GPs) manage most of the patients receiving
methadone maintenance treatment (MMT).
Methods: Using a cross-sectional postal survey of GPs who treat MMT patients and GPs who do
not, we studied the difficulties encountered in the out-patient management of drug-addicted
patients. We sent a questionnaire to every GP with MMT patients (556) in the French-speaking part
of Switzerland (1,757,000 inhabitants). We sent another shorter questionnaire to primary care
physicians without MMT patients living in the Swiss Canton of Vaud.
Results: The response rate was 63.3%. The highest methadone dose given by GPs to MMT patients
averaged 120.4 mg/day. When asked about help they would like to be given, GPs with MMT patients
primarily mentioned the importance of receiving adequate fees for the care they provide. Secondly,
they mentioned the importance of better training, better knowledge of psychiatric pathologies, and
discussion groups on practical cases. GPs without MMT patients refuse to treat these patients
mostly for emotional and relational reasons.
Conclusion: GPs encounter financial, relational and emotional difficulties with MMT patients.
They desire better fees for services and better training.
Background
Methadone maintenance treatment (MMT) is extensively
used for opiate addiction. Providing care in an office-
based practice is feasible [1,2] and produces outcomes
comparable to those from specialist treatment [1,3-7].
Furthermore, it reduces the stigma associated with the
diagnosis and treatment of substance abuse and increases
the amount of attention paid to medical and psychiatric
conditions [3,4]. Easy geographical access to treatment
encourages employment rehabilitation and retention in
treatment [4]. However, GPs encounter specific difficul-
ties with this population: burnout, lack of training, a neg-
ative attitude and a lack of motivation have been widely
reported [3,8,9]. These difficulties prevent some GPs from
accepting MMT patients.
Furthermore, each country manages MMT in a different
way: the UK encourages every general practitioner to pre-
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scribe methadone through national policies and guide-
lines; France usually reserves MMT for specialized centers
and promotes the use of buprenorphine [10]; and the
United States only recently began to allow GPs to pre-
scribe MMT.
In Switzerland, most patients on MMT are treated by GPs,
currently using the oral liquid form of methadone.
Buprenorphine use is very rare and codeine is not encour-
aged. Only some specialized centers treat opiate abusers
with injectable heroin. GPs have to register for every opi-
ate substitution with methadone to afford the double pre-
scription.
The Swiss government encourages substitution treatment
for drug-addicted individuals in the context of a harm-
reduction policy, but does not push GPs to accept these
patients and has never distributed national guidelines
broadly as has the UK. Generally, however, Swiss GPs are
used to providing pharmacotherapies and other treat-
ments to drug users in our country. There is no shared care
as in England, but Swiss GPs use a pragmatic approach,
including meeting with social workers and pharmacists in
charge of MMT patients. Groups of GPs involved with the
drug-addicted have been created and receive support from
the Federal Office of Public Health for continuous forma-
tion and clinical discussion.
Specialized centers with psychiatrists, social workers, psy-
chologists and medical doctors offer multidisciplinary
management for unstable patients. However, in Switzer-
land as elsewhere, there are not enough specialized cent-
ers for all drug addicts requiring treatment, and access is
limited by geographical barriers and the restricted number
of treatment places that can be offered [11]. Furthermore,
some geographical regions do not have specialized cent-
ers.
Office-based treatment provides clear advantages for
drug-abusing patients. However, primary care practition-
ers encounter specific difficulties with this patient popula-
tion. Burnout, lack of training, a negative attitude and a
lack of motivation have been reported widely among the
GP population [3,8,9]. These difficulties discourage and
prevent primary care physicians from accepting drug
abusers for substitution treatment.
The aims of this study were to (1) to describe the specific
difficulties with the MMT population encountered by pri-
mary care physicians and to identify why primary care
physicians are reluctant to manage drug-abusing patients
in Switzerland; and (2) to identify primary care physi-
cians' needs in terms of future management of drug-abus-
ing patients in the French-speaking part of Switzerland
and to suggest solutions to help them.
Methods
We mailed a multiple-choice questionnaire designed to
evaluate various aspects of the difficulties encountered in
treating MMT patients: pharmacological issues (highest
methadone dose), legal requirements, financial issues
(how GPs get paid), emotional and psychiatric aspects
(including psychiatric medication and referral to a psychi-
atrist), relationships, multidisciplinary interactions (e.g.
with social workers or with pharmacists), motivation of
primary care physicians, and specific management in the
office setting. We collected the material to develop this
questionnaire during semi-formal interviews with the
staff at Saint-Martin (a specialized center for managing
drug abusers). MedRoTox practitioners (a group of gen-
eral practitioners concerned with the problem of depend-
ency and supported by the Swiss Federal Office of Public
Health) reviewed the questionnaire. During the calendar
year 2000, we mailed it for anonymous completion to
every primary care practitioner with MMT patients in the
French-speaking part of Switzerland (556 physicians).
This figure includes every GP prescribing methadone in
this part of the country, which has a population of
1,757,000. We sent the questionnaire again three months
later to increase the response rate and received answers
over the following three months.
We sent another questionnaire to GPs without MMT
patients to evaluate more specifically the factors that kept
Table 1: Profile of office-based physicians with and without methadone substitution treatment
PT (n = 352) PWT (n = 231) X2, p value
Male 84.9% 82.7% X2 = 0.4; p = 0.563
Practice in a town with >10,000 inhabitants 60% 66.2%
Practice in a town with <10,000 inhabitants 40% 33.8% X2 = 2.3; p = 0.136
Works alone 57.9% 65.7%
Works in a group practice (with other doctors) 42.1% 34.3% X2 = 3.5; p = 0.068
Median no. of years in practice* (mean SD) 15 (14.8 ± 7.4) 17 (17 ± 8.6) Z = -3.2; p = 0.001
PT = General practitioners with patients receiving methadone substitution treatment
PWT = General practitioners without patients receiving methadone substitution treatment
*P value was calculated using the Mann-Whitney test; other P values were calculated using Fisher's exact testBMC Family Practice 2005, 6:51 http://www.biomedcentral.com/1471-2296/6/51
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them from accepting these patients. We used the mailing
list kept by the outpatient clinic at Lausanne University
Hospital. These 365 GPs represent most of the primary
care practitioners in the Swiss canton of Vaud. This ques-
tionnaire, also for anonymous completion, was also sent
twice at an interval of three months.
Both questionnaires are available from the corresponding
author.
We used descriptive statistics and the chi-square test for
comparison. We performed all statistical analyses by SPSS
software, version 11.
Results
Of the 556 targeted GPs with MMT patients (PT: practi-
tioners with MMT patients), 63.3% (352) responded. We
received replies from 231 (63%) of the targeted 365 pri-
mary care physicians without MMT patients (PWT: practi-
tioners without MMT patients). Table 1 shows the profiles
of both groups of GPs.
Both populations (PT and PWT) were similar in terms of
gender frequencies, practice location and the percentage
who work in a group practice. The only statistically signif-
icant difference was the mean number of years in medical
practice (PT: 14.8 years, PWT: 17 years).
Table 2: Of the total PTs respondents, 73% would not
accept more patients. The mean number (± SD) of MMT
patients that a PT would like to have (5.8 ± 6.9, median 4)
was slightly less than the mean number that they actually
treat (mean: 6.2 ± 9.04, median 4). Responding PTs
reported an average highest daily methadone dose of
120.4 mg/day (median = 100 mg/day, mode = 100 mg).
The percentage of PWTs who had received requests for
methadone treatment was 52%. Of the responding PWTs,
42.9% had been involved in methadone treatment in the
past but were no longer treating such patients. Of the
PWTs, 88.7% did not treat MMT patients because they
refused to accept them into their practice.
Table 3 shows the improvements reported by both PTs
and PWTs as necessary for improving MMT patient man-
agement. PTs mostly emphasized better reimbursement
for related items of service. They also frequently men-
tioned better training (post-graduate or specialized psy-
chiatric training) and more interaction with other
professionals, including groups for discussing clinical
cases. PWTs gave priority to having more centers and more
specialized professionals for treating drug-addicted
patients.
Table 3: What could be done to improve the management of patients on methadone maintenance treatment (MMT)?
Question: PT (n = 352) PWT (n = 231) X2 P
Better reimbursement for care 58.8% Question not asked
Better post-graduate training 50% 31.2% 56.9 < 0.001
Group discussion of clinical cases 50% 22.9% 42.8 < 0.001
Better knowledge of psychiatric pathologies 46.6% 21.2% 38.7 < 0.001
More political commitment to drug-addicted patients
(more centers, more specialized professionals)
44.6% 64.1% 21.2 < 0.001
More accessible specialized professionals 42% 37.2% 1.3 0.262
Better training at medical school 41.2% 19% 6.0 0.014
Better screening for drug addiction
by private practitioners
18.2% 16.5% 0.3 0.656
Stronger political repression of illegal drugs 9.7% 19.5% 11.5 0.001
PT = General practitioners with patients on methadone substitution treatment
PWT = General practitioners without patients on methadone substitution treatment
Table 2: General practitioners who treat patients with methadone substitution (PT, n = 352)
Would you accept new MMT patients? Yes: 23.9 % No: 73% (missing data: 3.1%)
Mean (SD) Median
Actual number of patients on methadone treatment? 6.2 (± 9.04) 4
How many patients would you like to have on MMT? 5.8 (± 6.9) 4
Highest daily dose of methadone you ever prescribed: 120.4 mg (± 95.9) 100 mg (mode: 100 mg)
PT = General practitioners with patients receiving methadone substitution treatment
PWT = General practitioners without patients receiving methadone substitution treatment
MMT = Methadone maintenance treatmentBMC Family Practice 2005, 6:51 http://www.biomedcentral.com/1471-2296/6/51
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Of the PT group, 56% of physicians reported difficulties
with medical care reimbursement (table 4). Also, a total of
76.1% had learned about MMT through their own prac-
tices rather than receiving formal training. Most PTs are
interested in investing time in further training.
Table 5 shows reasons why PWTs refuse MMT patients.
PWTs rated non-compliant patients as the biggest obstacle
to management (59.7%) and preferred patients to be
managed by a specialized center (57.1%). The "time-con-
suming" nature of treatment for drug-addicted patients
was another major reason (54.5%) cited for not accepting
them.
Discussion
The disinclination of the PWTs to treat MMT patients
(88.7%) raises the question of how to change this atti-
tude, especially in light of the growing need for MMT
(9,700 patients treated with methadone in 1991 and
15,382 in 1997 in Switzerland) [12] and the lack of spe-
cialized centers and government policies encouraging
easy access to MMT. More medical training, specific train-
ing during residency and the development of faculty role
models would probably contribute to improving attitudes
[7]. A strikingly high percentage of GPs refuse to treat
MMT patients for reasons linked to relationships or man-
agement of emotions (noncompliant patients, fears, feel-
ing of powerlessness, or burnout in the past, as illustrated
at Table 5). Again, better role models, a more positive atti-
tude during basic medical training and greater emotional
and professional support for practitioners involved with
MMT patients could perhaps overcome these barriers. Of
the PWTs, 11.3 % would still accept MMT patients. This
information suggests an area warranting further research,
and we need better tools to identify, reach, teach and
encourage these physicians.
The highest average daily dose of methadone (120.4 mg/
day, table 2) is not surprising in view of the recommenda-
tions in the literature: although daily doses of methadone
may differ from one patient to another, some authors rec-
ommend daily doses between 60 and 100 mg/day [15-
19]. A UK postal survey addressed to GPs in 2001 identi-
fied a mean methadone dose of 36.9 mg [14]; although
this information (the mean) differs from the information
obtained in our study (highest methadone dose pre-
scribed), our result is still higher than expected: generally,
GPs are known to prescribe low doses of methadone, con-
trary to international recommendations [14,16]. How-
ever, Swiss GPs with MMT patients seem to be more aware
of these recommendations. We hypothesize that PTs may
have better formation and could be more concerned
about methadone issues.
When asked how the management of MMT patients could
be improved (table 3), PTs first mentioned better reim-
bursement for services provided. In Switzerland, patients
pay part of the costs of health care, with the mandatory
health insurance system picking up the rest of the bill. In
some instances, health insurance companies reimburse
patients so that they can pay their physicians directly. This
practice was intended to create a stronger sense of respon-
sibility among patients for the cost of their medical treat-
ment. However, it is often difficult for a drug-addicted
patient to reimburse physicians with these funds; the
drug-addicted usually have difficulties with money man-
agement and may spend the money instead on illicit
drugs. If the patient does not pay, money is rapidly
deducted from the social help provided to pay the
monthly health insurance. But the physician may not
receive the portion for which the patient is responsible.
This payment system is specific to Switzerland but shows
that adequate reimbursement is important.
Weinrich and Stuart have demonstrated that professional
and financial help are crucial for primary care practition-
ers in Scotland [2]. In the UK, financial rewards for gen-
eral practitioners helped them to accept and continue
working with MMT patients [2,14].
Table 4: Questions about reimbursement and training for general practitioners who treat patients with methadone substitution (PT: n 
= 352)
Question yes
Do you have problems getting medical care reimbursed? 56.7%
How did you learn about MMT learning through their own practice? 76.1%
post-graduate training? 58%
self-taught? (books or scientific articles) 49.7%
during your internship? 15.6%
Would you like to participate in addiction-related training for doctors? 65.3%
Would you like to participate in workshops with physicians and others professionals involved in the field? 50%
PT = General practitioners with patients receiving methadone substitution treatment
MMT = Methadone maintenance treatmentBMC Family Practice 2005, 6:51 http://www.biomedcentral.com/1471-2296/6/51
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In contrast, PWTs suggest increasing the number of spe-
cialized centers and developing more accessible special-
ized professional help as the first steps towards improving
MMT patient management (table 5). These suggestions
are fully in keeping with their attitudes about not accept-
ing MMT patients. As the results showed, significantly
more PTs than PWTs felt that better postgraduate training
could improve the management of patients in MMT.
PTs mentioned lack of training as the second area for
improvement in the management of MMT patients, sug-
gesting better postgraduate formation, discussion groups
focusing on clinical cases, better knowledge of psychiatric
pathologies, and better training during residency. The
need of GPs for adequate training in addiction is well
known [9]. Miller et al. [13] emphasized the lack of spe-
cific training at medical schools and the absence of a pos-
itive attitude and role models among faculty and
physicians. In the French-speaking part of Switzerland,
two universities have medical schools. One (the Univer-
sity of Lausanne) offers a 12-hour teaching module
including alcohol- and drug-related dependence and one
day of practice in the psychiatric service; the other (the
University of Geneva) has 80 hours of teaching on alco-
hol- and drug-related problems. However, this formal
training in addiction began only a few years ago. Each
region also has its own training opportunities, depending
on the local network. Although local discussion groups
for clinical cases already exist, the high percentage of PTs
who expressed a need for more training points to a current
overall lack of training.
Our study found that 76.1% of PTs have learned through
their own daily practice how to manage methadone treat-
ment (table 4). This is another powerful illustration of the
lack of training that doctors receive and makes an urgent
case for the development of better training opportunities
for primary care practitioners who provide methadone
treatment in Switzerland.
Two concerns mentioned with similar frequency by PTs
were the need for more political support in the treatment
of drug-addicted patients (provision of more centers,
more specialized professionals) and the need for more
accessible specialists (table 3). Interestingly, PTs are more
interested in improving their own practices (through
reimbursement of fees and training) than in developing
other infrastructure for treating drug abusers. This finding
illustrates the concentration of MMT patient treatment in
the outpatient setting in Switzerland.
The median number of patients managed by the PTs rep-
resented in the survey is fairly low (four per practitioner,
table 2) but is comparable with a recent postal survey in
England (3.58 patients with opiate substitution per pre-
scribing GP) [14]. However, when asked how many MMT
patients they would like to treat, PTs responded with an
even lower number. This finding underlines the limited
capacity of a single physician to accept and treat MMT
patients and the burden represented by these patients. In
Switzerland, the primary care practitioners who accept
patients for methadone treatment probably represent
those doctors who are more trained and more interested
in MMT patients.
Our study has some limitations. First, the PWT popula-
tion was sampled from the Canton of Vaud. We intention-
ally chose this Canton because it includes both an urban
and a rural population. Both survey populations (PT and
PWT) were similar in terms of sex, location in a village or
a town (>10,000 inhabitants) and the type of practice
(single or shared). The only statistically significant differ-
ence was the mean number of years of practice in the two
populations. Age and training in treating drug misuse
have been shown to affect attitude (9); thus, younger prac-
titioners may be more likely to consider MMT patients as
medical patients than as stigmatized individuals. Further-
more, older practitioners were not as accustomed to deliv-
ering methadone.
The response rate to the survey (63.3% of PT and 63% of
PWT) is another limitation. Although it is a high rate for a
nine-page questionnaire, the survey still represents the
opinions of only some practitioners. Compared with the
Table 5: Why do you refuse care for methadone treatment 
patients (general practitioners with no patients on methadone 
substitution treatment) (PWTs) (n = 231)
Question yes
Non-compliant patients 59.7%
A specialized center is better 57.1%
Time-consuming 54.5%
Lack of specialized training 52.4%
Fear of being overwhelmed by drug-addicted patients 48.9%
Feeling of powerlessness toward drug-addicted patients 41.6%
Difficulties with authorizations (too much paperwork) 40.3%
Lack of reimbursement for medical care 38.1%
Management with other professionals too difficult 38.1%
Difficulties with accompanying psychiatric disorders 36.4%
Fear of manipulation by drug-addicted patients 33.3%
Lack of knowledge about illegal substances and medications 31.2%
Past experience of burnout with drug-addicted patients 29.4%
Fear of theft 28.1%
Fear of problems with other, non-drug-addicted patients 27.7%
Fear of being threatened in the office 24.7%
Fear of being considered "the drug-addict doctor" 11.7%
Existing centers are adequate for this population 11.3%
PWT = General practitioners without patients receiving methadone 
substitution treatmentBMC Family Practice 2005, 6:51 http://www.biomedcentral.com/1471-2296/6/51
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literature, it was better than expected from a busy general
practice [20]. Even if the return rate was similar for PTs
and PWTs, there could be a bias of greater interest in the
subject or of greater personal involvement.
A final limitation is the fact that the questionnaire was not
formally validated by inter-rater techniques.
Conclusion
Each country has specific needs and characteristics for
drug management, depending on government policies
and the existing health care network. Switzerland has a
policy of decentralization and harm reduction based on a
low-threshold approach and a broad access to MMT
through GPs, a policy embroiled in major political and
emotional controversies. "Shared care" only exists in spe-
cialized centers in the form of multidisciplinary work with
drug nurses, psychiatrists, social workers and GPs, but is
reserved for more disruptive and unstable patients. In
Switerzland, MMT prescribed outside specialized centers
involves only a highly selected group of GPs trained in the
addiction field. National policies, however, encourage
GPs to work in multidisciplinary teams and to meet regu-
larly with social workers and other healthcare providers.
If the intention is specifically to achieve a low-threshold
approach through generalizing MMT prescription, we
need to listen to suggestions made by the principal play-
ers, i.e. the general practitioners. PTs want reimbursement
for their services and better training. The growing needs of
drug-addicted patients, the spread of HIV and the greater
emphasis on harm-reduction policies are surely powerful
reasons for answering this plea and providing support to
practitioners who accept MMT patients.
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